Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014

References

• Johnson JD, Young B. Demographics of brain metastasis. Neurosurg Clin N Am. 1996;7:337–344.
   PubMed Web of Science ®Google Scholar
• Law A, Karp DD, Dipetrillo T, et al. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma. Cancer. 2001;92:160–164.
   PubMed Web of Science ®Google Scholar
• Peters S, Bexelius C, Munk V, et al. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer. Cancer Treat Rev. 2016;45:139–162.
   PubMed Web of Science ®Google Scholar
• IKNL-Integraal Kankercentrum Nederland/Comprehensive Cancer Centre the Netherlands. Oncoline Cancer Clinical Guidelines: Hersenmetastasen (Guideline Brain Metastasis). 2011.
   Google Scholar
• Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. In: Tsao MN, editor. Cochrane database of systematic reviews. Chichester (UK): John Wiley & Sons, Ltd; 2012.
   Google Scholar
• Khanduri S, Gerrard G, Barton R, et al. Clinical trials assessing the optimal management of brain metastases – the state of play. Clin Oncol. 2006;18:744–746.
   PubMed Web of Science ®Google Scholar
• Scoccianti S, Ricardi U. Treatment of brain metastases: review of phase III randomized controlled trials. Radiother Oncol. 2012; 102:168–179.
   PubMed Web of Science ®Google Scholar
• Horton J, Baxter DH, Olson KB. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med. 1971;111:334–336.
   PubMedGoogle Scholar
• Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority. Lancet. 2016;388:2004–2014.
   PubMed Web of Science ®Google Scholar
• Pechoux CL, Dhermain F, Besse B. Whole brain radiotherapy in patients with NSCLC and brain metastases. Lancet. 2016;388: 1960–1962.
   PubMed Web of Science ®Google Scholar
• Bruynzeel AME, Lagerwaard FJ. Whole brain radiotherapy for brain metastases from non-small cell lung cancer: the end of an era? J Thorac Dis. 2016;8:E1525–E1527.
   PubMed Web of Science ®Google Scholar
• Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751.
   PubMed Web of Science ®Google Scholar
• Nieder C, Andratschke NH, Geinitz H, et al. Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries. Med Sci Monit. 2012;18:CR450–CR455.
   PubMed Web of Science ®Google Scholar
• Tsao MN, Sultanem K, Chiu D, et al. Supportive care management of brain metastases: what is known and what we need to know. Conference proceedings of the National Cancer Institute of Canada (NCIC) Workshop on Symptom Control in Radiation Oncology. Clin Oncol. 2003;15:429–434.
   Web of Science ®Google Scholar
• Wong E, Tsao M, Zhang L, et al. Survival of patients with multiple brain metastases treated with whole-brain radiotherapy. CNS Oncol. 2015;4:213–224.
   PubMedGoogle Scholar
• Nieder C, Norum J, Dalhaug A, et al. Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors. Clin Exp Metastasis. 2013;30:723–729.
   PubMed Web of Science ®Google Scholar
• Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence – what is it and what can it tell us? N Engl J Med. 2016;375: 2293–2297.
   PubMed Web of Science ®Google Scholar
• Windsor AA, Koh E-S, Allen S, et al. Poor outcomes after whole brain radiotherapy in patients with brain metastases: results from an international multicentre cohort study. Clin Oncol. 2013; 25:674–680.
   Web of Science ®Google Scholar
• Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012;30:419–425.
   PubMed Web of Science ®Google Scholar
• Lutterbach J, Bartelt S, Stancu E, et al. Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3. Radiother Oncol. 2002;63:339–345.
   PubMed Web of Science ®Google Scholar
• Paggi MG, Vona R, Abbruzzese C, et al. Gender-related disparities in non-small cell lung cancer. Cancer Lett. 2010;298:1–8.
   PubMed Web of Science ®Google Scholar
• Hendriks LEL, Troost EGC, Steward A, et al. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: impact of a new Dutch guideline on brain metastases. Acta Oncol. 2014;53:945–951.
   PubMed Web of Science ®Google Scholar
• Khan M, Lin J, Liao G, et al. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: review and meta-analysis. Tumour Biol. 2017;39:1010428317702903.
   Google Scholar
• Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014;15:387–395.
   PubMed Web of Science ®Google Scholar
• Soliman H, Das S, Larson DA, et al. Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases. Oncotarget. 2016;7:12318–12330.
   PubMed Web of Science ®Google Scholar
• Zindler JD, Bruynzeel AME, Eekers DBP, et al. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial. BMC Cancer. 2017;17:500.
   PubMed Web of Science ®Google Scholar
• Bezjak A, Adam J, Barton R, et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer. 2002;38:487–496.
   PubMed Web of Science ®Google Scholar
• Chow E, Davis L, Holden L, et al. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage. 2005;30:18–23.
   PubMed Web of Science ®Google Scholar
• Pulenzas N, Khan L, Tsao M, et al. Fatigue scores in patients with brain metastases receiving whole brain radiotherapy. Support Care Cancer. 2014;22:1757–1763.
   PubMed Web of Science ®Google Scholar
• Soffietti R, Kocher M, Abacioglu UM, et al. A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31:65–72.
   PubMed Web of Science ®Google Scholar
• Tsao MN, Lloyd N, Wong RK, et al. 2006. Whole brain radiotherapy for the treatment of multiple brain metastases. In: Tsao MN, editor. Cochrane database of systematic reviews. Chichester (UK): John Wiley & Sons, Ltd.
   Google Scholar